JOIN THE FIGHT
Recurrent C. difficile can be debilitating, isolating, and sometimes life threatening. No one should have to live in fear of another infection.
That’s why we’re enrolling PRISM 3, a clinical study of investigational capsules designed to prevent the cycles of C. difficile.
The investigational treatment, called CP101, is a capsule designed to deliver a full community of beneficial bacteria to the areas of the intestine affected by C. difficile. The study drug, like fecal microbiota transplantation (FMT), is intended to restore the ecosystem found in a healthy human gut. But unlike traditional fecal transplants, which usually involve colonoscopies or enemas, CP101 is an odorless capsule taken orally.
An oral pill designed to repair the microbiome – no bowel prep or colonoscopy
Dedicated, experienced medical care
Free transportation and coverage of all study-related costs
18 years or older
Have had more than one episode of C. difficile infection
Have been prescribed antibiotics for the most recent C. difficile infection
Do not have inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS)
-or- use the below map to contact a doctor near you